Publications in collaboration with researchers from Sarah Cannon Research Institute (1)

2014

  1. Phase lb study of buparlisib plus trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on trastuzumab-based therapy

    Clinical Cancer Research, Vol. 20, Núm. 7, pp. 1935-1945